NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

感染疾病迅速診斷檢驗的全球市場:各產品、各用途、各終端用戶、各地區的預測 (2021年∼2028年)

Global Infectious Disease Rapid Diagnostics Testing Market - By Product, By Application, and End User, and By Region - Global forecast from 2021-2028

出版商 SPER Market Research Pvt. Ltd. 商品編碼 1004282
出版日期 內容資訊 英文 118 Pages
商品交期: 最快1-2個工作天內
價格
感染疾病迅速診斷檢驗的全球市場:各產品、各用途、各終端用戶、各地區的預測 (2021年∼2028年) Global Infectious Disease Rapid Diagnostics Testing Market - By Product, By Application, and End User, and By Region - Global forecast from 2021-2028
出版日期: 2021年01月01日內容資訊: 英文 118 Pages
簡介

全球感染疾病迅速診斷檢驗的市場規模,預計在預測期間內 (2021年∼2028年) 大幅度擴大。市場主要促進因素,是各種感染疾病、慢性疾病的擴大伴隨的急速診斷套件 (含妊娠檢測套組)的需求增加,及分子診斷技術的發展與用途擴大等。各產品中的OTC (商店用) 市場區隔,各用途中的感染疾病產品,各終端用戶中的家用市場佔最大的佔有率。在各地區中,北美各國預計有大幅度的市場成長。

本報告提供全球感染疾病迅速診斷檢驗的市場相關分析,市場基本結構和主要的影響要素,整體市場規模趨勢預測,各產品、各用途、各最終用途的市場佔有率結構,各地區的詳細趨勢,主要企業簡介等調查。

目錄

第1章 分析策略與市場趨勢

第2章 分析方法

第3章 摘要整理

第4章 市場洞察

  • 供應鏈分析
  • 經濟要素分析
    • 促進因素
    • 市場趨勢
    • 市場機會
    • 課題
  • 市場參與企業與產品分析
  • 法律規範
  • 各企業的市場佔有率分析 (2021年)
  • 波特的五力分析
  • 新投資分析
  • PESTEL分析

第5章 全球感染疾病迅速診斷檢驗市場:概要

  • 市場規模與其預測 (2016年∼2028年)
    • 需求趨勢
  • 市場佔有率與其預測 (2016年∼2028年)
    • 各產品
    • 各用途
    • 各最終用途
    • 各地區

第6章 歐洲的感染疾病迅速診斷檢驗市場:概要

  • 市場規模與其預測 (2016年∼2028年)
    • 需求趨勢
  • 市場佔有率與其預測 (2016年∼2028年)
    • 各產品
    • 各用途
    • 各最終用途
    • 各國
    • 各企業市場佔有率 (前3名∼5名公司)
    • 對歐洲的感染疾病迅速診斷檢驗市場的經濟影響分析

第7章 北美的感染疾病迅速診斷檢驗市場:概要

第8章 亞太地區的感染疾病迅速診斷檢驗市場:概要

第9章 南美的感染疾病迅速診斷檢驗市場:概要

第10章 中東、非洲的感染疾病迅速診斷檢驗市場:概要

第11章 市場參與企業分析

  • 企業概要
  • 財務分析
  • 主要產品
  • 主要的經營幹部
  • 聯絡原住所
  • SWOT分析
  • 企業簡介
目錄

The Global infectious disease rapid diagnostics testing market emerge the market growth owing to cost-effective diagnosis device and prevalence of chronic diseases.

The Global infectious disease rapid diagnostics testing market will fuel CAGR in the forecast period from 2021-2028. The prevalence of contagious diseases spreading through pathogens, viruses, and microorganisms coupled with chronic conditions, has emerged the market demand for the global infectious disease rapid diagnostics testing market.

The rapid diagnosis kits market demand emerging due to the rising diseases such as cancer, diabetics, HIV, as well pregnancy kits also contributed to developing the market demand for the global infectious disease rapid diagnostics testing market.

Moreover, In-vitro diagnosis has a prestigious sub-division, molecular diagnosis applied to the fields of infectious disease diagnosis, blood screening, genetic disease diagnosis, and molecular tumor diagnosis. The wide range of uses has promoted the rapid development of the molecular diagnosis industry, which will propel the market demand for global infectious disease early diagnostics testing market.

Product Overview in the Global infectious disease rapid diagnostics testing Market

Based on product, the global infectious disease rapid diagnostics testing market bifurcated into Over the Counter [OTC] Rapid Test Product and Professional Rapid Test Product. The Over the Counter [OTC] Rapid Test Product segment has captured the highest market value in the global infectious disease rapid diagnostics testing market. It is mainly owing to the effective functioning of the quick diagnosis tests kit, which provides accurate and fast results.

Application Overview in the Global infectious disease rapid diagnostics testing Market

Based on the Application, the global infectious disease rapid diagnostics testing market classified into Infectious Disease, Cardiology, Oncology, Pregnancy & Fertility, Toxicology, Glucose Monitoring, and Others. The infectious diseases hold the largest market share in the global infectious disease rapid diagnostics testing market. The increasing prevalence of chronic diseases such as STD, HIV, and other contagious diseases have bolstered the demand for the infectious disease early diagnostics testing and will continue to strengthen in the future as well.

End-User Overview in the Global infectious disease rapid diagnostics testing Market

Based on the End-user, the global infectious disease rapid diagnostics testing segmented into Hospital & Clinic, Diagnostic Laboratory, Home Care, and Others. The Homecare segment has dominated the market of the global infectious disease rapid diagnostics testing market. It is due to the emerging demand for diabetic patients and quick test kits also used for a pregnancy test at home. Therefore, the home care segment is fueling the market share of the global infectious disease rapid diagnostics testing market.

Region Overview in the Global infectious disease rapid diagnostics testing Market

Based on geography, the global infectious disease rapid diagnostics testing market segmented into North America, Asia Pacific, Europe, South America, and Middle East & Africa. The North America region will be expecting to witness the highest growth during the forecast period from 2021-2028. Owing to technological advancement, the adoption of the rapid diagnostic testing device, and investment in research and development for the manufacturing of new methods used in the healthcare industry are emerging market of infectious disease quick diagnostics testing market of North America.

Global infectious disease rapid diagnostics testing Market: Competitive Landscape

Companies such as

Abbott Laboratories

Becton

Dickinson and Company

Biomerieux SA

Danaher Corporation

Bio-Rad Laboratories

Diasorin

Luminex

Quidel

Meridian Bioscience

Roche Diagnostics

Siemens AG

Thermo Fisher Scientific

and others are key players in the global infectious disease rapid diagnostics testing market.

Table of Contents

1. Research Strategic Development

  • 1.1. Market Modelling
  • 1.2. Product Analysis
  • 1.3. Market Trend and Economic Factors Analysis
  • 1.4. Market Segmental Analysis
  • 1.5. Geographical Mapping
  • 1.6. Country Wise Segregation

2. Research Methodology

  • 2.1. Identification of Target Market
  • 2.2. Data Acquisition
  • 2.3. Refining of Data/ Data Transformations
  • 2.4. Data Validation through Primary Techniques
  • 2.5. Exploratory Data Analysis
  • 2.6. Graphical Techniques/Analysis
  • 2.7. Quantitative Techniques/Analysis
  • 2.8. Visual Result/Presentation

3. Executive Summary

4. Market Insights

  • 4.1. Economic Factor Analysis
    • 4.1.1. Drivers
    • 4.1.2. Trends
    • 4.1.3. Opportunities
    • 4.1.4. Challenges
  • 4.2. Competitors & Product Analysis
  • 4.3. Regulatory Framework
  • 4.4. Company market share analysis, 2021
  • 4.5. Porter's Five forces analysis
  • 4.6. New Investment Analysis
  • 4.7. PESTEL Analysis

5. Global Infectious Disease Rapid Diagnosis Testing Market Overview

  • 5.1. Market Size & Forecast, 2016-2028
    • 5.1.1. Demand
      • 5.1.1.1. By Value (USD Million)
  • 5.2. Market Share & Forecast, 2016-2028
    • 5.2.1. By Product
      • 5.2.1.1. Over-the-Counter (OTC) Rapid Test Product
      • 5.2.1.2. Professional Rapid Test Product
    • 5.2.2. By Application
      • 5.2.2.1. Infectious Disease
      • 5.2.2.2. Cardiology
      • 5.2.2.3. Oncology
      • 5.2.2.4. Pregnancy & Fertility
      • 5.2.2.5. Toxicology
      • 5.2.2.6. Glucose Monitoring
      • 5.2.2.7. Others
    • 5.2.3. By End-use
      • 5.2.3.1. Hospital & Clinic
      • 5.2.3.2. Diagnostic Laboratory
      • 5.2.3.3. Home Care
      • 5.2.3.4. Others
    • 5.2.4. By Region
      • 5.2.4.1. Europe
      • 5.2.4.2. North America
      • 5.2.4.3. Asia Pacific
      • 5.2.4.4. South America
      • 5.2.4.5. Middle East & Africa

6. Europe Infectious Disease Rapid Diagnosis Testing Market Overview

  • 6.1. Europe Infectious Disease Rapid Diagnosis Testing Size & Forecast, 2016-2028
    • 6.1.1. Demand
      • 6.1.1.1. By Value (USD Million)
  • 6.2. Europe Infectious Disease Rapid Diagnosis Testing Market Share & Forecast, 2016-2028
    • 6.2.1. By Product
      • 6.2.1.1. Over-the-Counter (OTC) Rapid Test Product
      • 6.2.1.2. Professional Rapid Test Product
    • 6.2.2. By Application
      • 6.2.2.1. Infectious Disease
      • 6.2.2.2. Cardiology
      • 6.2.2.3. Oncology
      • 6.2.2.4. Pregnancy & Fertility
      • 6.2.2.5. Toxicology
      • 6.2.2.6. Glucose Monitoring
      • 6.2.2.7. Others
    • 6.2.3. By End-use
      • 6.2.3.1. Hospital & Clinic
      • 6.2.3.2. Diagnostic Laboratory
      • 6.2.3.3. Home Care
      • 6.2.3.4. Others
    • 6.2.4. By Country
      • 6.2.4.1. Germany
      • 6.2.4.2. UK
      • 6.2.4.3. France
      • 6.2.4.4. Italy
      • 6.2.4.5. Rest of Europe
    • 6.2.5. Company Market Share (Top 3-5)
    • 6.2.6. Economic Impact Study on Europe Infectious Disease Rapid Diagnosis Testing Market

7. North America Infectious Disease Rapid Diagnosis Testing Market Overview

  • 7.1. North America Infectious Disease Rapid Diagnosis Testing Market Size & Forecast, 2016-2028
    • 7.1.1. Demand
      • 7.1.1.1. By Value (USD Million)
  • 7.2. North America Infectious Disease Rapid Diagnosis Testing Market Share & Forecast, 2016-2028
    • 7.2.1. By Product
      • 7.2.1.1. Over-the-Counter (OTC) Rapid Test Product
      • 7.2.1.2. Professional Rapid Test Product
    • 7.2.2. By Application
      • 7.2.2.1. Infectious Disease
      • 7.2.2.2. Cardiology
      • 7.2.2.3. Oncology
      • 7.2.2.4. Pregnancy & Fertility
      • 7.2.2.5. Toxicology
      • 7.2.2.6. Glucose Monitoring
      • 7.2.2.7. Others
    • 7.2.3. By End-use
      • 7.2.3.1. Hospital & Clinic
      • 7.2.3.2. Diagnostic Laboratory
      • 7.2.3.3. Home Care
      • 7.2.3.4. Others
    • 7.2.4. By Country
      • 7.2.4.1. US
      • 7.2.4.2. Canada
      • 7.2.4.3. Mexico
    • 7.2.5. Company Market Share (Top 3-5)
    • 7.2.6. Economic Impact Study on North America Infectious Disease Rapid Diagnosis Testing Market

8. Asia Pacific Infectious Disease Rapid Diagnosis Testing Overview

  • 8.1. Asia Pacific Infectious Disease Rapid Diagnosis Testing Market Size & Forecast, 2016-2028
    • 8.1.1. Demand
      • 8.1.1.1. By Value (USD Million)
  • 8.2. Asia Pacific Infectious Disease Rapid Diagnosis Testing Market Share & Forecast, 2016-2028
    • 8.2.1. By Product
      • 8.2.1.1. Over-the-Counter (OTC) Rapid Test Product
      • 8.2.1.2. Professional Rapid Test Product
    • 8.2.2. By Application
      • 8.2.2.1. Infectious Disease
      • 8.2.2.2. Cardiology
      • 8.2.2.3. Oncology
      • 8.2.2.4. Pregnancy & Fertility
      • 8.2.2.5. Toxicology
      • 8.2.2.6. Glucose Monitoring
      • 8.2.2.7. Others
    • 8.2.3. By End-use
      • 8.2.3.1. Hospital & Clinic
      • 8.2.3.2. Diagnostic Laboratory
      • 8.2.3.3. Home Care
      • 8.2.3.4. Others
    • 8.2.4. By Country
      • 8.2.4.1. China
      • 8.2.4.2. India
      • 8.2.4.3. Japan
      • 8.2.4.4. Australia
      • 8.2.4.5. Rest of Asia Pacific
    • 8.2.5. Company Market Share (Top 3-5)
    • 8.2.6. Economic Impact Study on Asia Pacific Infectious Disease Rapid Diagnosis Testing Market

9. South America Infectious Disease Rapid Diagnosis Testing Market Overview

  • 9.1. South America Infectious Disease Rapid Diagnosis Testing Market Size & Forecast, 2016-2028
    • 9.1.1. Demand
      • 9.1.1.1. By Value (USD Million)
  • 9.2. South America Infectious Disease Rapid Diagnosis Testing Market Share & Forecast, 2016-2028
    • 9.2.1. By Product
      • 9.2.1.1. Over-the-Counter (OTC) Rapid Test Product
      • 9.2.1.2. Professional Rapid Test Product
    • 9.2.2. By Application
      • 9.2.2.1. Infectious Disease
      • 9.2.2.2. Cardiology
      • 9.2.2.3. Oncology
      • 9.2.2.4. Pregnancy & Fertility
      • 9.2.2.5. Toxicology
      • 9.2.2.6. Glucose Monitoring
      • 9.2.2.7. Others
    • 9.2.3. By End-use
      • 9.2.3.1. Hospital & Clinic
      • 9.2.3.2. Diagnostic Laboratory
      • 9.2.3.3. Home Care
      • 9.2.3.4. Others
    • 9.2.4. By Country
      • 9.2.4.1. Brazil
      • 9.2.4.2. Argentina
      • 9.2.4.3. Rest of South America
    • 9.2.5. Company Market Share (Top 3-5)
    • 9.2.6. Economic Impact Study on South America Infectious Disease Rapid Diagnosis Testing Market

10. Middle East & Africa Infectious Disease Rapid Diagnosis Testing Market Overview

  • 10.1. Middle East & Africa Infectious Disease Rapid Diagnosis Testing Market Size & Forecast, 2016-2028
    • 10.1.1. Demand
      • 10.1.1.1. By Value (USD Million)
  • 10.2. Middle East & Africa Infectious Disease Rapid Diagnosis Testing Market Share & Forecast, 2016-2028
    • 10.2.1. By Product
      • 10.2.1.1. Over-the-Counter (OTC) Rapid Test Product
      • 10.2.1.2. Professional Rapid Test Product
    • 10.2.2. By Application
      • 10.2.2.1. Infectious Disease
      • 10.2.2.2. Cardiology
      • 10.2.2.3. Oncology
      • 10.2.2.4. Pregnancy & Fertility
      • 10.2.2.5. Toxicology
      • 10.2.2.6. Glucose Monitoring
      • 10.2.2.7. Others
    • 10.2.3. By End-use
      • 10.2.3.1. Hospital & Clinic
      • 10.2.3.2. Diagnostic Laboratory
      • 10.2.3.3. Home Care
      • 10.2.3.4. Others
    • 10.2.4. By Country
      • 10.2.4.1. Saudi Arabia
      • 10.2.4.2. UAE
      • 10.2.4.3. South Africa
      • 10.2.4.4. Rest of Middle East & Africa
    • 10.2.5. Company Market Share (Top 3-5)
    • 10.2.6. Economic Impact Study on Middle East & Africa Infectious Disease Rapid Diagnosis Testing Market

11. Competitor Analysis

  • 11.1. Company Description
  • 11.2. Financial Analysis
  • 11.3. Key Products
  • 11.4. Key Management Personnel
  • 11.5. Contact Address
  • 11.6. SWOT Analysis
  • 11.7. Company Profile
      • 11.7.1.1. Abbott Laboratories
      • 11.7.1.2. Becton, Dickinson and Company
      • 11.7.1.3. Biomerieux SA
      • 11.7.1.4. Bio-Rad Laboratories
      • 11.7.1.5. Danaher Corporation
      • 11.7.1.6. Diasorin
      • 11.7.1.7. Luminex
      • 11.7.1.8. Meridian Bioscience
      • 11.7.1.9. Quidel
      • 11.7.1.10. Roche Diagnostics
      • 11.7.1.11. Siemens AG
      • 11.7.1.12. Thermo Fisher Scientific
      • 11.7.1.13. Other players